High-Dose Crizotinib for Brain Metastases Refractory to Standard-Dose Crizotinib

被引：40
|
作者：
Kim, Young Hak [1 ]
Ozasa, Hiroaki [1 ]
Nagai, Hiroki [1 ]
Sakamori, Yuichi [1 ]
Yoshida, Hironori [1 ]
Yagi, Yoshitaka [1 ]
Nakaoku, Takashi [1 ]
Mishima, Michiaki [1 ]
机构：
[1] Kyoto Univ, Dept Resp Med, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷 / 09期
关键词：
CELL LUNG-CANCER; PATIENT;
D O I：
10.1097/JTO.0b013e31829cebbb
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：e85 / e86
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib
    Cheung, Justin M.
    Kang, Jiyoon
    Yeap, Beow Y.
    Peterson, Jennifer L.
    Do, Andrew
    Gainor, Justin F.
    Digumarthy, Subba R.
    Lin, Jessica J.
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (03):
  • [22] Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor
    Cui, Yuehong
    Li, Qian
    Yu, Yiyi
    Chen, Yong
    Feng, Yi
    Wang, Yan
    Liu, Tianshu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 145 - 152
  • [23] Distribution of brain metastases: implications for non-uniform dose prescriptions
    Bender, E. T.
    Tome, W. A.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1003): : 649 - 658
  • [24] High-Dose Furmonertinib in Patients With EGFR-Mutated NSCLC and Leptomeningeal Metastases: A Prospective Real-World Study
    Chen, Haiyang
    Yang, Sen
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    He, Zhen
    Zhang, Cuicui
    Liu, Yang
    Tang, Haoran
    Dong, Hang
    Wang, Qiming
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (01) : 65 - 75
  • [25] High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases-One with a remarkable thoracic response as well
    Kuiper, J. L.
    Smit, E. F.
    LUNG CANCER, 2013, 80 (01) : 102 - 105
  • [26] A 'Hybrid' Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
    Ji, Hongshan
    Zhou, Zhiguo
    CANCERS, 2022, 14 (14)
  • [27] CT-Guided Biopsy of Entirely Endophytic Small Renal Masses: Diagnostic Rates and Complications Using Standard-Dose and Reduced-Dose CT Protocols
    Kim, Mi-hyun
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 208 (05) : 1030 - 1036
  • [28] High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review
    Reese, Nicholas D.
    Schiller, Gary J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (02) : 141 - 148
  • [29] A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours
    Gazzah, Anas
    Boni, Valentina
    Soria, Jean-Charles
    Calles, Antonio
    Even, Caroline
    Doger, Bernard
    Mahjoubi, Linda
    Bahleda, Rastislav
    Ould-Kaci, Mahmoud
    Esler, Anne
    Nazabadioko, Serge
    Calvo, Emiliano
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 1 - 8
  • [30] Cushing's disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
    Wong, Mimi
    Malabu, Usman H.
    Korah, Ipeson
    Tan, YongMong
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2021,
12345